The number of people with susceptibility test result for rifampicin in Central African Republic
Central African Republic: The number of people with susceptibility test result for rifampicin was 9.75 in 2021. ◆ Volatile
Latest (2021)
9.75
Change on year
down 7.0%
World rank
139th
of 146 countries
All-time high
10.49
in 2020
All-time low
0.3482
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Central African Republic, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Central African Republic is 9.75, measured in 2021.
Compared with earlier readings it is down 7.0% on the previous year and up 2,699.6% over five years.
Central African Republic ranks 139th of 146 countries on this measure, in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Central African Republic, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 0.3482 | — |
| 2018 | 0.6978 | +100.4% |
| 2019 | 3.87 | +454.8% |
| 2020 | 10.49 | +170.8% |
| 2021 | 9.75 | -7.0% |
Central African Republic compared with similar countries
- Central African Republic's 9.75 is below the median for low income countries, which is 37.16, 26% of the median. (13 countries reporting)
- Central African Republic's 9.75 is below the median for Sub-Saharan Africa, which is 61.16, 16% of the median. (32 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1.64 | 0.3482 | 3.87 | 3 |
| 2020s | 10.12 | 9.75 | 10.49 | 2 |
Countries ranked near Central African Republic
- 136 Congo, Democratic Republic of the 22.3 compare
- 137 Madagascar 15.83 compare
- 138 Niger 11.2 compare
- 140 Venezuela, Bolivarian Republic of 3.31 compare
- 141 France 1.45 compare
- 142 South Sudan 0 compare
- 142 Grenada 0 compare
- 142 Sao Tome and Principe 0 compare
- 142 Vanuatu 0 compare
- 142 Mauritania 0 compare
More health data for Central African Republic
- Un projection of annual infant deaths, annual growth rate -1.88 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.15 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 887.2 deaths per 1,000 people (2090)
- Number of infants who die before age 1 5,728 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 4.9 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0002 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0934 units per person (2025)
- Population ages 00-04, male, annual growth rate 4.96 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0002 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Central African Republic?
- The number of people with susceptibility test result for rifampicin in Central African Republic was 9.75 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Central African Republic?
- The highest recorded value was 10.49 in 2020.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Central African Republic?
- The lowest recorded value was 0.3482 in 2017.
- How does Central African Republic rank for the number of people with susceptibility test result for rifampicin?
- Central African Republic ranks 139th out of 146 countries with data for 2021.
- Where does this Central African Republic data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).